{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:51:02Z","timestamp":1780609862469,"version":"3.54.1"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:00:00Z","timestamp":1365033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002164","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T18:19:10Z","timestamp":1365099550000},"page":"e2164","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Combined TLR7\/8 and TLR9 Ligands Potentiate the Activity of a Schistosoma japonicum DNA Vaccine"],"prefix":"10.1371","volume":"7","author":[{"given":"Xuefeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Shih","family":"Hoellwarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI34261","article-title":"Helminth infections: the great neglected tropical diseases","volume":"118","author":"PJ Hotez","year":"2008","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1056\/NEJMp0808041","article-title":"Toward the elimination of schistosomiasis","volume":"360","author":"CH King","year":"2009","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"MJ Doenhoff","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00436-009-1371-7","article-title":"Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges","volume":"104","author":"R Abdul-Ghani","year":"2009","journal-title":"Parasitol Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1017\/S0031182009990400","article-title":"The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002\u20132008","volume":"136","author":"A Fenwick","year":"2009","journal-title":"Parasitology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"DP McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?","volume":"21","author":"NR Bergquist","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1479-5876-7-18","article-title":"Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs","volume":"7","author":"MM Aloysius","year":"2009","journal-title":"J Transl Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1128\/JVI.78.23.13082-13089.2004","article-title":"CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1","volume":"78","author":"FN Toka","year":"2004","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1002\/eji.200939335","article-title":"CD4+CD25+ Treg induction by an HSP60-derived peptide SJMHE1 from <italic>Schistosoma japonicum<\/italic> is TLR2 dependent","volume":"39","author":"X Wang","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00436-010-2089-2","article-title":"Effect of CD4+ CD25+ regulatory T cells on the immune evasion of <italic>Schistosoma japonicum<\/italic>","volume":"108","author":"CL Tang","year":"2011","journal-title":"Parasitol Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e16860","DOI":"10.1371\/journal.pone.0016860","article-title":"Regulatory and activated T cells in human <italic>Schistosoma haematobium<\/italic> infections","volume":"6","author":"N Nausch","year":"2011","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.icb.7100014","article-title":"Immunopathology of schistosomiasis","volume":"85","author":"MS Wilson","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-387827-4.00003-6","article-title":"Regulatory T cells in infection","volume":"112","author":"RM Maizels","year":"2011","journal-title":"Adv Immunol"},{"key":"ref15","first-page":"243","article-title":"[Regulatory T cell depletion increases the number of CD8 cells during mouse mammary tumor virus infection]","volume":"71","author":"G Cabrera","year":"2011","journal-title":"Medicina (B Aires)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1073\/pnas.1015148108","article-title":"Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points","volume":"108","author":"KK Dietze","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"S Akira","year":"2001","journal-title":"Nat Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1473-3099(11)70099-8","article-title":"Targeting of Toll-like receptors: a decade of progress in combating infectious diseases","volume":"11","author":"M Hedayat","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/intimm\/dxl136","article-title":"TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell","volume":"19","author":"E Chiffoleau","year":"2007","journal-title":"Int Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.imlet.2006.12.007","article-title":"CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells","volume":"108","author":"DF LaRosa","year":"2007","journal-title":"Immunol Lett"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1113401","article-title":"Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function","volume":"309","author":"G Peng","year":"2005","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cellimm.2010.03.002","article-title":"The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus","volume":"262","author":"ML Salem","year":"2010","journal-title":"Cell Immunol"},{"key":"ref23","first-page":"133","article-title":"Therapeutic applications of nucleic acids as ligands for Toll-like receptors","volume":"11","author":"G Panter","year":"2009","journal-title":"Curr Opin Mol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/j.ijid.2010.02.2266","article-title":"Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with <italic>Schistosoma mansoni<\/italic> in mice","volume":"14","author":"G Ahmad","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e40359","DOI":"10.1371\/journal.pone.0040359","article-title":"Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protection","volume":"7","author":"X Wang","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"F Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1756-3305-3-109","article-title":"The nature and combination of subunits used in epitope-based <italic>Schistosoma japonicum<\/italic> vaccine formulations affect their efficacy","volume":"3","author":"X Wang","year":"2010","journal-title":"Parasit Vectors"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/j.vaccine.2008.05.034","article-title":"Enhancement by IL-18 of the protective effect of a <italic>Schistosoma japonicum<\/italic> 26 kDa GST plasmid DNA vaccine in mice","volume":"26","author":"F Wei","year":"2008","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming","volume":"5","author":"A Martin-Fontecha","year":"2004","journal-title":"Nat Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1016\/j.vaccine.2011.05.061","article-title":"Vaccine adjuvant activity of 3 M-052: an imidazoquinoline designed for local activity without systemic cytokine induction","volume":"29","author":"D Smirnov","year":"2011","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.micinf.2007.11.009","article-title":"T cell epitope-based peptide-DNA dual vaccine induces protective immunity against <italic>Schistosoma japonicum<\/italic> infection in C57BL\/6J mice","volume":"10","author":"L Zhang","year":"2008","journal-title":"Microbes Infect"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.20030422","article-title":"Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells","volume":"198","author":"S Yamazaki","year":"2003","journal-title":"J Exp Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2006-03-011353","article-title":"Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients","volume":"108","author":"DK Banerjee","year":"2006","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2005-10-4015","article-title":"Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo","volume":"108","author":"T Warger","year":"2006","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2567.2007.02651.x","article-title":"Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells","volume":"122","author":"G Liu","year":"2007","journal-title":"Immunology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","article-title":"CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production","volume":"188","author":"AM Thornton","year":"1998","journal-title":"J Exp Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.4049\/jimmunol.176.7.3900","article-title":"Cutting edge: IL-4-induced protection of CD4+CD25- Th cells from CD4+CD25+ regulatory T cell-mediated suppression","volume":"176","author":"L Pace","year":"2006","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4049\/jimmunol.178.1.271","article-title":"IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions","volume":"178","author":"S Wan","year":"2007","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2009.03053.x","article-title":"Regulatory T cells overturned: the effectors fight back","volume":"126","author":"LS Walker","year":"2009","journal-title":"Immunology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"X Valencia","year":"2006","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2353\/ajpath.2009.080987","article-title":"Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications","volume":"174","author":"S Andre","year":"2009","journal-title":"Am J Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cellimm.2006.08.003","article-title":"Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses","volume":"241","author":"J Li","year":"2006","journal-title":"Cell Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni1179","article-title":"A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3","volume":"6","author":"JD Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature05479","article-title":"Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression","volume":"445","author":"YY Wan","year":"2007","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/eji.201041014","article-title":"Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs","volume":"41","author":"D Hackl","year":"2011","journal-title":"Eur J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of defined TLR ligands as adjuvants within human vaccines","volume":"239","author":"MS Duthie","year":"2011","journal-title":"Immunol Rev"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/path.2284","article-title":"Macrophage activation by endogenous danger signals","volume":"214","author":"X Zhang","year":"2008","journal-title":"J Pathol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"WW Zhang","year":"2008","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.vaccine.2004.01.037","article-title":"Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model","volume":"22","author":"M Otero","year":"2004","journal-title":"Vaccine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/ecp.11.5","article-title":"The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system","volume":"4","author":"AL Engel","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/cimm.2000.1689","article-title":"Adjuvant activities of immune response modifier R-848: comparison with CpG ODN","volume":"204","author":"JP Vasilakos","year":"2000","journal-title":"Cell Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.1000238","article-title":"Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis","volume":"185","author":"VS Raman","year":"2010","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI39293","article-title":"Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice","volume":"120","author":"Q Zhu","year":"2010","journal-title":"J Clin Invest"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1371\/journal.pntd.0000597","article-title":"<italic>Schistosoma mansoni<\/italic> Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection","volume":"4","author":"LP Farias","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1371\/journal.pntd.0000308","article-title":"<italic>Schistosoma mansoni<\/italic> tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection","volume":"2","author":"FC Cardoso","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni1223","article-title":"Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells","volume":"6","author":"G Napolitani","year":"2005","journal-title":"Nat Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0805325105","article-title":"Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines","volume":"105","author":"Q Zhu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.onc.1210910","article-title":"TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours","volume":"27","author":"H Conroy","year":"2008","journal-title":"Oncogene"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ijc.25399","article-title":"An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma","volume":"128","author":"C Jacobs","year":"2011","journal-title":"Int J Cancer"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.4049\/jimmunol.0904084","article-title":"Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses","volume":"184","author":"DB Hoelzinger","year":"2010","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"T Kawai","year":"2007","journal-title":"Semin Immunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"S Sakaguchi","year":"2009","journal-title":"Int Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine","volume":"226","author":"DM Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1101\/gad.1791009","article-title":"Molecular orchestration of differentiation and function of regulatory T cells","volume":"23","author":"LF Lu","year":"2009","journal-title":"Genes Dev"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2005.06.024","article-title":"TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)","volume":"23","author":"RD Weeratna","year":"2005","journal-title":"Vaccine"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri3095","article-title":"TLR-dependent T cell activation in autoimmunity","volume":"11","author":"KH Mills","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2230.2005.01938.x","article-title":"Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas","volume":"31","author":"N Rajan","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.4049\/jimmunol.176.10.5839","article-title":"Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population","volume":"176","author":"JJ Taylor","year":"2006","journal-title":"J Immunol"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T17:28:30Z","timestamp":1562866110000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002164"}},"subtitle":[],"editor":[{"given":"Malcolm K.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":68,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002164","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}